CP and neoplasm: When tumor‐bearing mice were treated repeatedly with CP, adding DIPH to the treatment regimen did not decrease the Pt adduct burden in the DNA of lung tumor cells in situ nor the treatment efficacy (average tumor size per number of nodules; Fig. S4).